On the shoulders of a giant: an appraisal of the legacy of Dr. Gerald P Bodey to infectious diseases.
[BACKGROUND] Gerald P.
APA
Kontoyiannis DP, Lewis RE, et al. (2026). On the shoulders of a giant: an appraisal of the legacy of Dr. Gerald P Bodey to infectious diseases.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 32(4), 572-577. https://doi.org/10.1016/j.cmi.2025.11.008
MLA
Kontoyiannis DP, et al.. "On the shoulders of a giant: an appraisal of the legacy of Dr. Gerald P Bodey to infectious diseases.." Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 32, no. 4, 2026, pp. 572-577.
PMID
41242465
Abstract
[BACKGROUND] Gerald P. Bodey (1934-2020) was a pioneering haematologist who revolutionized the management of infectious complications in patients with haematological malignancies. Over 4 decades, he authored >800 peer-reviewed publications and established evidence-based practices that continue to save lives worldwide.
[OBJECTIVES] To examine Bodey's seminal contributions to infectious diseases in immunocompromised hosts and their enduring impact on contemporary cancer care.
[SOURCES] Beginning with his seminal paper on the relationship between infections and circulating neutrophils, this review synthesizes Dr. Bodey's research accomplishments from the 1960s through 2000s, organising his work into chronologically arranged principles that shaped modern oncology practice.
[CONTENT] Seven key principles emerge from Bodey's work: (1) the critical importance of autopsy data for understanding infection epidemiology; (2) quantitative risk assessment using neutrophil counts, establishing the 500 cells/mm threshold for empirical antibiotic therapy; (3) timely empirical antibiotic therapy in febrile neutropenic patients; (4) the necessity of studying antibiotics specifically in neutropenic populations; (5) environmental control strategies and prophylaxis; (6) recognition of fungal infections as persistent threats; and (7) mentorship and academic excellence in developing future leaders.
[IMPLICATIONS] Bodey's foundational work established the framework for modern infection management in cancer patients. His quantitative approach to infection risk assessment and empirical antibiotic therapy became standard care for >5 decades. As cancer treatment evolves toward targeted therapies with novel immunosuppressive effects, Bodey's principles require adaptation but remain fundamentally relevant. His legacy demonstrates the importance of rigorous clinical research, mentorship, and patient-focused care in advancing medical knowledge and improving outcomes.
[OBJECTIVES] To examine Bodey's seminal contributions to infectious diseases in immunocompromised hosts and their enduring impact on contemporary cancer care.
[SOURCES] Beginning with his seminal paper on the relationship between infections and circulating neutrophils, this review synthesizes Dr. Bodey's research accomplishments from the 1960s through 2000s, organising his work into chronologically arranged principles that shaped modern oncology practice.
[CONTENT] Seven key principles emerge from Bodey's work: (1) the critical importance of autopsy data for understanding infection epidemiology; (2) quantitative risk assessment using neutrophil counts, establishing the 500 cells/mm threshold for empirical antibiotic therapy; (3) timely empirical antibiotic therapy in febrile neutropenic patients; (4) the necessity of studying antibiotics specifically in neutropenic populations; (5) environmental control strategies and prophylaxis; (6) recognition of fungal infections as persistent threats; and (7) mentorship and academic excellence in developing future leaders.
[IMPLICATIONS] Bodey's foundational work established the framework for modern infection management in cancer patients. His quantitative approach to infection risk assessment and empirical antibiotic therapy became standard care for >5 decades. As cancer treatment evolves toward targeted therapies with novel immunosuppressive effects, Bodey's principles require adaptation but remain fundamentally relevant. His legacy demonstrates the importance of rigorous clinical research, mentorship, and patient-focused care in advancing medical knowledge and improving outcomes.
MeSH Terms
Humans; History, 20th Century; Communicable Diseases; History, 21st Century; Immunocompromised Host; Hematologic Neoplasms